-
Clodronate Liposomes for Macrophage Studies
2026-08-28
Clodronate Liposomes provide a flexible way to test whether macrophages causally shape tumor immunity, inflammation, or tissue repair in vivo. This guide connects route selection, matched controls, tissue profiling, and troubleshooting to the CCL7–TAM findings reported in colorectal cancer immunotherapy research.
-
Extracellular Vesicle Inhibition in TNBC
2026-08-28
McNamee et al. examined whether distinct extracellular vesicle populations drive aggressive trait transfer in triple-negative breast cancer and whether pharmacological inhibition can reduce that communication. Their integrated analysis shows that broad suppression of vesicle release, rather than selective targeting of one putative vesicle class, may be necessary to substantially limit functional effects on recipient cells.
-
Nilotinib (AMN-107) for Kinase Signaling Research
2026-08-27
Nilotinib (AMN-107) enables controlled interrogation of BCR-ABL, KIT, and related tyrosine kinase signaling in cellular and translational models. This guide combines practical dosing workflows with phosphatase-aware assay design inspired by a recent p38α study, helping researchers distinguish pathway suppression from irreversible cell loss.
-
JNJ-26854165 (Serdemetan) Assay Guide
2026-08-27
This scenario-based guide explains how JNJ-26854165 (Serdemetan), SKU A4204, can support interpretable proliferation, viability, apoptosis, and radiosensitization experiments. It combines product-specific preparation data with literature-based guidance for separating growth arrest from cell death in cancer research.
-
Disodium bicinchoninate for Reliable Cell Assays
2026-08-26
Learn how Disodium bicinchoninate, SKU C6645, can strengthen protein normalization and aqueous biochemical workflows supporting cell viability, proliferation, and cytotoxicity studies. This scenario-based guide separates established BCA assay principles from practical optimization recommendations and highlights compatibility, interpretation, and vendor-selection considerations.
-
Ferrostatin-1 (Fer-1) for Ferroptosis Assays
2026-08-26
Ferrostatin-1 (Fer-1) provides a practical rescue-control strategy for connecting lipid peroxidation with ferroptotic cell death in cancer, neuronal, and injury models. This guide translates AR/GPX4 pathway findings into assay design, dosing, controls, and troubleshooting steps.
-
Triacetin Workflows for GBM and Metabolic Research
2026-08-25
Triacetin supports parallel oncology, metabolic, and ocular formulation workflows through a hydrolysable acetate–glycerol structure and broad solvent compatibility. This guide converts reported activity ranges into practical assay designs, controls, troubleshooting steps, and a cautious precision-research framework.
-
FPS-ZM1 and RAGE: From Metabolism to AD
2026-08-25
RAGE biology is emerging as a translational bridge between metabolic dysfunction, neuronal stress, amyloid beta transport, and neuroinflammation. This thought-leadership article examines how FPS-ZM1 can help researchers isolate RAGE-dependent mechanisms while defining the evidence and experimental safeguards needed before extending hypothalamic metabolic findings into Alzheimer’s disease research.
-
IEM-1925 Against Soman-Induced Status Epilepticus
2026-08-24
A 2026 rat study evaluated IEM-1925, a dual AMPA/NMDA glutamate receptor antagonist, after soman-induced status epilepticus. The treatment reduced seizure burden, improved survival, limited hippocampal injury, and lessened anxiety-like and cognitive deficits, supporting glutamate-receptor targeting as a preclinical neuroprotection strategy.
-
Puerarin Activates NO Signaling in Dental Follicle Cells
2026-08-24
The study by Cao and colleagues shows that puerarin enhances the osteogenic differentiation of rat dental follicle cells and links this effect to activation of the nitric oxide–cGMP signaling axis. Its use of L-NMMA-mediated pathway inhibition provides pharmacological evidence that nitric oxide signaling contributes to the observed regenerative phenotype, while also defining important limitations for translation to periodontal disease models.
-
SM-102 for Localized mRNA Delivery Research
2026-08-23
SM-102 is a lipid nanoparticle component for efficient mRNA delivery, but its value extends beyond generic formulation optimization. This article examines how SM-102 can be evaluated in localized therapeutic workflows, using intravesical p21 mRNA delivery as a translational assay framework.
-
Early-Life Adversity, Oxytocin, and Innate Defense
2026-08-22
A 2026 Communications Biology study links early-life adversity to impaired looming-evoked innate defensive behavior through reduced oxytocin signaling in the superior colliculus. Its combination of behavioral testing, circuit analysis, receptor knockdown, and intranasal oxytocin treatment provides a mechanistic framework for studying how developmental stress alters threat processing.
-
Cholesterol Hinders LNP Intracellular Trafficking
2026-08-22
Luo and colleagues developed a sensitive tracking platform to examine how lipid nanoparticle composition affects intracellular movement of nucleic acid cargo. Their results indicate that increased cholesterol promotes accumulation of LNP–nucleic acid complexes in peripheral early endosomes, whereas DSPC can reduce this aggregation and help preserve downstream trafficking.
-
Novel PDK4 Inhibitors for Metabolic Disease
2026-08-21
The reference study used anthraquinone-based hit optimization to identify compound 8c, a potent allosteric pyruvate dehydrogenase kinase 4 inhibitor with metabolic, allergic-disease, and anticancer activity in preclinical models. Its integrated biochemical, pharmacokinetic, animal, cellular, and docking data establish a useful scaffold for further PDK4 drug-discovery research while leaving selectivity, safety, and clinical translation unresolved.
-
p-Cresyl Sulfate: From Toxin to Assay Design
2026-08-20
Explore how p-Cresyl sulfate and p-tolyl hydrogen sulfate can support mechanistically resolved studies of endothelial dysfunction, valvular calcification, and uremic cardiovascular injury. This guide emphasizes phenotype selection, albumin-aware exposure design, and evidence-based assay interpretation.